SAN FRANCISCO (Reuters) – A U.S. appeals court on Tuesday revived a shareholder lawsuit against Allergan Inc over allegations that the company improperly marketed and labeled the cosmetic drug Botox. U.S. court revives shareholder lawsuit vs. Allergan over Botox Reuters: Business News
